Gyroscope Therapeutics Hldgs Ltd (VISN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | 0 | 0 | -246,520 | 0 |
| Depreciation Amortization | 0 | 0 | 0 | 7,770 | 0 |
| Income taxes - deferred | 0 | 0 | 0 | -7,673 | 0 |
| Accounts receivable | 0 | 0 | 0 | 25,092 | 0 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | -8,536 | 0 |
| Other Working Capital | 0 | 0 | 0 | 28,680 | 0 |
| Other Operating Activity | 0 | 0 | 0 | 173,998 | 0 |
| Operating Cash Flow | $0 | $0 | $0 | $-27,190 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | -1,800 | 0 |
| Purchase Sale Intangibles | 0 | 0 | 0 | -109 | 0 |
| Other Investing Activity | 0 | 0 | 0 | -11,310 | 0 |
| Investing Cash Flow | $0 | $0 | $0 | $-13,110 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 0 | 31,852 | 0 |
| Debt Repayment | 0 | 0 | 0 | -43,485 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 39 | 0 |
| Other Financing Activity | 0 | 0 | 0 | 4 | 0 |
| Financing Cash Flow | $0 | $0 | $0 | $-11,590 | $0 |
| Exchange Rate Effect | 0 | 0 | 0 | 600 | 0 |
| Beginning Cash Position | 0 | 0 | 0 | 80,310 | 0 |
| End Cash Position | 0 | 0 | 0 | 29,010 | 0 |
| Net Cash Flow | $0 | $0 | $0 | $-51,290 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | 0 | 0 | -27,190 | 0 |
| Capital Expenditure | 0 | 0 | 0 | -1,802 | 0 |
| Free Cash Flow | 0 | 0 | 0 | -28,992 | 0 |